NCT05367362View on ClinicalTrials.gov

Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2027

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Minocyclin

200 mg intravenous/oral minocycline hydrochloride for a total of 21 days

All Listed Sponsors

lead

State University of New York at Buffalo

OTHER